NDC product
Pilocarpine hydrochloride
NDC 0228-2837 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0228-2837 |
|---|---|
| Proprietary name | Pilocarpine hydrochloride |
| Nonproprietary name | Pilocarpine hydrochloride |
| Substances | PILOCARPINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Actavis Pharma, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA020237 |
| Pharmacologic classes | Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC] |
| Marketing start | Sep 13, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: